4//SEC Filing
Jensen Klavs F. 4
Accession 0000899243-20-030319
CIK 0001604477other
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 8:00 PM ET
Size
9.3 KB
Accession
0000899243-20-030319
Insider Transaction Report
Form 4
Jensen Klavs F.
Director
Transactions
- Conversion
Series Seed Convertible Preferred Stock
2020-11-03−7,017→ 0 total→ Common Stock (7,388 underlying) - Conversion
Common Stock
2020-11-03+14,662→ 338,982 total - Conversion
Series B Convertible Preferred Stock
2020-11-03−6,908→ 0 total→ Common Stock (7,274 underlying)
Footnotes (1)
- [F1]The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock automatically converted on a 1.053 for one basis into common stock upon the closing of the Issuer's initial public offering. The shares have no expiration date.
Documents
Issuer
SQZ Biotechnologies Co
CIK 0001604477
Entity typeother
Related Parties
1- filerCIK 0001829257
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 8:00 PM ET
- Size
- 9.3 KB